NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

Reckon you've got all the favorites for CI patnership listed, Mav.

But:-

"Hey, wait! Don't forget AstraZeneca's checkpoint inhibitor

AstraZeneca ($AZN) has been doing everything it can to move up in the frenetic race to develop new checkpoint inhibitors, and it made its best effort with a preliminary snapshot of positive results for a combination of the anti-PD-L1 MEDI4736 and tremelimumab in lung cancer. Up to now 18 patients have been treated and 5--or 28%--had responded with signs of tumor shrinkage, according to a Reuters report from Madrid. "It looks very, very promising," Scott Antonia of the Moffitt Cancer Center in Florida told Ben Hirschler. It also looks like very, very early data."

-Fierce Biotech.



And:-

Not to forget GSK. Probably the outsider as they don't have a CI, and are already tied up with Adaptimmune.

However.....

"The group has at least a dozen oncology assets in clinical development, most at an early stage but including some promising new approaches that Axel Hoos, its head of oncology R&D, believes could be at the forefront of the next generation of cancer therapies."

"Mr Hoos says GSK is only interested in “transformational” cancer drugs that are either first-in-class or highly differentiated from rivals. Many observers will remain sceptical until further clinical data arrives but at least GSK has put itself back on the oncology map"

http://www.ft.com/cms/s/0/079b6a84-f82f-11e5-96db-fc683b5e52db.html#axzz4JtIvARLA